Apyx medical corporation reports second quarter 2025 financial results

Clearwater, fla., aug. 07, 2025 (globe newswire) -- apyx medical corporation (nasdaq:apyx) (“apyx medical;” the “company”), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as renuvion® and the ayon body contouring system™ (ayon), today reported financial results for its quarter ended june 30, 2025.
APYX Ratings Summary
APYX Quant Ranking